PKI News and Press, PerkinElmer Inc. From 08/18/22

Stifel has downgraded PerkinElmer ( NYSE: PKI ) from buy to hold following the recent announcement that Jamey Mock is leaving as the company's CFO . The firm also reduced its price target to $170 from $190 (~13% upside based on Wednesday's close). Analyst Daniel Ar...

Waters Corporation has continued to grow its top line, but some bottom line results have been weak. Fortunately, the picture for the year as a whole continues to look up and the firm's long-term outlook will probably be positive. But shares do not make for an attractive purchase a...

PerkinElmer ( NYSE: PKI ) announced Wednesday the departure of senior vice president and chief financial officer Jamey Mock as he joins Moderna ( MRNA ) as its finance chief . The Board of healthcare diagnostics company, PerkinElmer, has named Max Krakowi...

Moderna ( NASDAQ: MRNA ) has appointed James Mock as Chief Financial Officer, beginning September 6, 2022. James will serve on company's Executive Committee and report to Chief Executive Officer Stéphane Bancel. Current CFO David Meline will retire on th...

Max Krakowiak appointed new chief financial officer, replacing Jamey Mock PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Senior Vice President and Chief Financial Officer Jamey Mock will be transition...

PerkinElmer, Inc. (PKI) Q2 2022 Earnings Conference Call August 04, 2022, 08:00 ET Company Participants Stephen Willoughby - VP, IR Prahlad Singh - CEO, President & Director James Mock - SVP & CFO Conference Call Participants Daniel Arias - St...

The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: PerkinElmer, Inc. 2022 Q2 - Results - Earnings Call Presentation

PerkinElmer ( NYSE: PKI ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open. The consensus EPS Estimate is $1.44 (-49.1% Y/Y) and the consensus Revenue Estimate is $1.03B (-20.8% Y/Y). Over the last 2 years, PKI has beaten EPS e...

ABMD , ABUS , ACIW , ADAP , OTCQX:ADDYY , ADT , AG , AGIO , AHH , APD , APO , APTV , ARW , ATI , AUPH , AUTL , AZEK , BABA , BALL , BALY , OTCPK:BAYZF , BCE , BCRX , BDX , BKI , CBRE , ...

Following an earnings-led rally yesterday, the shares of life sciences company PerkinElmer, Inc. ( NYSE: PKI ) traded lower in the morning hours Tuesday after Bank of America downgraded the stock to Neutral from Buy citing limited upside potential. However, the analyst Der...